Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Uric Acid and Surgical Prognosis

N/ACompletedNCT06837545
Asan Medical Center309,353 enrolled

Overview

Preoperative serum uric acid significantly impacted mortality and morbidity in non-cardiac surgery.

Preoperative SUA levels demonstrate a nonlinear, sex-specific relationship with postoperative outcomes in non-cardiac surgery.

Study Type

OBSERVATIONAL

Enrollment

309,353

Conditions

Uric Acid

Interventions

No Intervention (Observational Study)OTHER

This study is an observational analysis of preoperative serum uric acid levels and their association with postoperative outcomes. No intervention was administered."

Eligibility

Sex: ALLMin age: 18 Years
Medical Language ↔ Plain English
Inclusion Criteria: * Patients aged 18 years or older * Patients who underwent non-cardiac surgery Exclusion Criteria: * Emergency surgery * Pregnancy * Cadavers * Patients with missing preoperative SUA values or no follow-up after surgery

Locations (1)

Asan Medical Center

Seoul, Songpa, South Korea

Outcomes

Primary Outcomes

30-day postoperative mortality

The primary outcome measure is the incidence of 30-day postoperative mortality in patients undergoing non-cardiac surgeries. Mortality is defined as death occurring within 30 days following the surgery.

Time frame: 30 days post-surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.